140 related articles for article (PubMed ID: 16214174)
21. CD4+ICOS+ T lymphocytes inhibit T cell activation 'in vitro' and attenuate autoimmune encephalitis 'in vivo'.
Rojo JM; Pini E; Ojeda G; Bello R; Dong C; Flavell RA; Dianzani U; Portolés P
Int Immunol; 2008 Apr; 20(4):577-89. PubMed ID: 18310064
[TBL] [Abstract][Full Text] [Related]
22. Induction of the genes for Cxcl9 and Cxcl10 is dependent on IFN-gamma but shows differential cellular expression in experimental autoimmune encephalomyelitis and by astrocytes and microglia in vitro.
Carter SL; Müller M; Manders PM; Campbell IL
Glia; 2007 Dec; 55(16):1728-39. PubMed ID: 17902170
[TBL] [Abstract][Full Text] [Related]
23. Pathophysiology of interleukin-23 in experimental autoimmune encephalomyelitis.
Touil T; Fitzgerald D; Zhang GX; Rostami AM; Gran B
Drug News Perspect; 2006 Mar; 19(2):77-83. PubMed ID: 16628262
[TBL] [Abstract][Full Text] [Related]
24. IL-21 receptor expression determines the temporal phases of experimental autoimmune encephalomyelitis.
Liu R; Bai Y; Vollmer TL; Bai XF; Jee Y; Tang YY; Campagnolo DI; Collins M; Young DA; La Cava A; Shi FD
Exp Neurol; 2008 May; 211(1):14-24. PubMed ID: 18353312
[TBL] [Abstract][Full Text] [Related]
25. Gene expression analysis suggests that 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by stimulating inflammatory cell apoptosis.
Spach KM; Pedersen LB; Nashold FE; Kayo T; Yandell BS; Prolla TA; Hayes CE
Physiol Genomics; 2004 Jul; 18(2):141-51. PubMed ID: 15138306
[TBL] [Abstract][Full Text] [Related]
26. The Ifng gene is essential for Vdr gene expression and vitamin D₃-mediated reduction of the pathogenic T cell burden in the central nervous system in experimental autoimmune encephalomyelitis, a multiple sclerosis model.
Spanier JA; Nashold FE; Olson JK; Hayes CE
J Immunol; 2012 Sep; 189(6):3188-97. PubMed ID: 22896638
[TBL] [Abstract][Full Text] [Related]
27. Early administration of IL-12 suppresses EAE through induction of interferon-gamma.
Gran B; Chu N; Zhang GX; Yu S; Li Y; Chen XH; Kamoun M; Rostami A
J Neuroimmunol; 2004 Nov; 156(1-2):123-31. PubMed ID: 15465603
[TBL] [Abstract][Full Text] [Related]
28. A chimeric TCR-beta chain confers increased susceptibility to EAE.
Petersen TR; Lata R; Spittle E; Bäckström BT
Mol Immunol; 2007 Jul; 44(14):3473-81. PubMed ID: 17481734
[TBL] [Abstract][Full Text] [Related]
29. CNS gene expression pattern associated with spontaneous experimental autoimmune encephalomyelitis.
Matejuk A; Hopke C; Dwyer J; Subramanian S; Jones RE; Bourdette DN; Vandenbark AA; Offner H
J Neurosci Res; 2003 Sep; 73(5):667-78. PubMed ID: 12929134
[TBL] [Abstract][Full Text] [Related]
30. T-bet regulates Th1 responses through essential effects on GATA-3 function rather than on IFNG gene acetylation and transcription.
Usui T; Preiss JC; Kanno Y; Yao ZJ; Bream JH; O'Shea JJ; Strober W
J Exp Med; 2006 Mar; 203(3):755-66. PubMed ID: 16520391
[TBL] [Abstract][Full Text] [Related]
31. Absence of PI3Kgamma leads to increased leukocyte apoptosis and diminished severity of experimental autoimmune encephalomyelitis.
Rodrigues DH; Vilela MC; Barcelos LS; Pinho V; Teixeira MM; Teixeira AL
J Neuroimmunol; 2010 May; 222(1-2):90-4. PubMed ID: 20303183
[TBL] [Abstract][Full Text] [Related]
32. PPARδ deficient mice develop elevated Th1/Th17 responses and prolonged experimental autoimmune encephalomyelitis.
Kanakasabai S; Walline CC; Chakraborty S; Bright JJ
Brain Res; 2011 Feb; 1376():101-12. PubMed ID: 21192919
[TBL] [Abstract][Full Text] [Related]
33. PPARgamma antagonists exacerbate neural antigen-specific Th1 response and experimental allergic encephalomyelitis.
Raikwar HP; Muthian G; Rajasingh J; Johnson C; Bright JJ
J Neuroimmunol; 2005 Oct; 167(1-2):99-107. PubMed ID: 16091293
[TBL] [Abstract][Full Text] [Related]
34. IFN-beta inhibits human Th17 cell differentiation.
Ramgolam VS; Sha Y; Jin J; Zhang X; Markovic-Plese S
J Immunol; 2009 Oct; 183(8):5418-27. PubMed ID: 19783688
[TBL] [Abstract][Full Text] [Related]
35. Elevation of Sema4A implicates Th cell skewing and the efficacy of IFN-β therapy in multiple sclerosis.
Nakatsuji Y; Okuno T; Moriya M; Sugimoto T; Kinoshita M; Takamatsu H; Nojima S; Kimura T; Kang S; Ito D; Nakagawa Y; Toyofuku T; Takata K; Nakano M; Kubo M; Suzuki S; Matsui-Hasumi A; Uto-Konomi A; Ogata A; Mochizuki H; Sakoda S; Kumanogoh A
J Immunol; 2012 May; 188(10):4858-65. PubMed ID: 22491253
[TBL] [Abstract][Full Text] [Related]
36. 17Beta-estradiol treatment profoundly down-regulates gene expression in spinal cord tissue in mice protected from experimental autoimmune encephalomyelitis.
Matejuk A; Dwyer J; Hopke C; Vandenbark AA; Offner H
Arch Immunol Ther Exp (Warsz); 2003; 51(3):185-93. PubMed ID: 12894873
[TBL] [Abstract][Full Text] [Related]
37. Deficient p75 low-affinity neurotrophin receptor expression does alter the composition of cellular infiltrate in experimental autoimmune encephalomyelitis in C57BL/6 mice.
Küst B; Mantingh-Otter I; Boddeke E; Copray S
J Neuroimmunol; 2006 May; 174(1-2):92-100. PubMed ID: 16519950
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA223 promotes pathogenic T-cell development and autoimmune inflammation in central nervous system in mice.
Satoorian T; Li B; Tang X; Xiao J; Xing W; Shi W; Lau KH; Baylink DJ; Qin X
Immunology; 2016 Aug; 148(4):326-38. PubMed ID: 27083389
[TBL] [Abstract][Full Text] [Related]
39. Latent TGF-beta1-transduced CD4+ T cells suppress the progression of allergic encephalomyelitis.
Murano M; Xiong X; Murano N; Salzer JL; Lafaille JJ; Tsiagbe VK
J Leukoc Biol; 2006 Jan; 79(1):140-6. PubMed ID: 16244108
[TBL] [Abstract][Full Text] [Related]
40. An interferon-gamma-producing Th1 subset is the major source of IL-17 in experimental autoimmune encephalitis.
Suryani S; Sutton I
J Neuroimmunol; 2007 Feb; 183(1-2):96-103. PubMed ID: 17240458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
